109 related articles for article (PubMed ID: 12700895)
1. Korea-Japan, JCRCO and UICC joint symposium on cancer and aging research: molecular epidemiological and translational studies.
Park SC; Yuasa Y; Lim IK; Yamamoto T; Goto S; Nakachi K
J Cancer Res Clin Oncol; 2003 Apr; 129(4):252-7. PubMed ID: 12700895
[No Abstract] [Full Text] [Related]
2. Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice.
Johnson TM; Attardi LD
Cell Death Differ; 2006 Jun; 13(6):902-8. PubMed ID: 16557272
[No Abstract] [Full Text] [Related]
3. The Seoul Symposium of the Journal of Cancer Research and Clinical Oncology Regulation of aging and carcinogenesis.
Lim IK; Park SC; Fujiki H
J Cancer Res Clin Oncol; 2000 Jul; 126(7):418-23. PubMed ID: 10929765
[No Abstract] [Full Text] [Related]
4. Highlights of the Twelfth Japan-Korea Joint Symposium on Cancer and Ageing Research.
Suganuma M; Park TJ; Sueoka E; Iida K; Tanaka Y
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1953-61. PubMed ID: 25820597
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
6. Translational research? Ribosome integrity and a new p53 tumor suppressor checkpoint.
Opferman JT; Zambetti GP
Cell Death Differ; 2006 Jun; 13(6):898-901. PubMed ID: 16557265
[No Abstract] [Full Text] [Related]
7. Signal transduction pathways leading to cell cycle arrest and apoptosis induction in cancer cells by Allium vegetable-derived organosulfur compounds: a review.
Herman-Antosiewicz A; Singh SV
Mutat Res; 2004 Nov; 555(1-2):121-31. PubMed ID: 15476856
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factors and neoplasia.
Pollak MN; Schernhammer ES; Hankinson SE
Nat Rev Cancer; 2004 Jul; 4(7):505-18. PubMed ID: 15229476
[No Abstract] [Full Text] [Related]
9. Cancer and aging: the molecular pathways.
Bassi P; Sacco E
Urol Oncol; 2009; 27(6):620-7. PubMed ID: 19879472
[TBL] [Abstract][Full Text] [Related]
10. Signal transduction pathways in cancer development and as targets for cancer prevention.
Bode AM; Dong Z
Prog Nucleic Acid Res Mol Biol; 2005; 79():237-97. PubMed ID: 16096030
[No Abstract] [Full Text] [Related]
11. The significance of autophagy in cancer.
Ng G; Huang J
Mol Carcinog; 2005 Aug; 43(4):183-7. PubMed ID: 16001423
[TBL] [Abstract][Full Text] [Related]
12. p53: more research and more questions.
Braithwaite AW; Prives CL
Cell Death Differ; 2006 Jun; 13(6):877-80. PubMed ID: 16708075
[No Abstract] [Full Text] [Related]
13. The malignant transformation event as a clonal transformation of apoptosis to anti-apoptosis pathways and of cell cycle dynamics.
Agius LM
Med Hypotheses; 2004; 62(6):914-8. PubMed ID: 15142647
[TBL] [Abstract][Full Text] [Related]
14. The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis: review article.
Lamberti A; Caraglia M; Longo O; Marra M; Abbruzzese A; Arcari P
Amino Acids; 2004 Jul; 26(4):443-8. PubMed ID: 15290352
[TBL] [Abstract][Full Text] [Related]
15. Hallmarks for senescence in carcinogenesis: novel signaling players.
Caino MC; Meshki J; Kazanietz MG
Apoptosis; 2009 Apr; 14(4):392-408. PubMed ID: 19169823
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and molecular pathology at crossroads to establish causation: molecular mechanisms of malignant transformation.
Bocchetta M; Carbone M
Oncogene; 2004 Aug; 23(38):6484-91. PubMed ID: 15322519
[TBL] [Abstract][Full Text] [Related]
17. Pathways of apoptotic and non-apoptotic death in tumour cells.
Okada H; Mak TW
Nat Rev Cancer; 2004 Aug; 4(8):592-603. PubMed ID: 15286739
[No Abstract] [Full Text] [Related]
18. Cancer as "rejuvenescence".
Ukraintseva SV; Yashina AI
Ann N Y Acad Sci; 2004 Jun; 1019():200-5. PubMed ID: 15247014
[TBL] [Abstract][Full Text] [Related]
19. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.
Bierie B; Moses HL
Nat Rev Cancer; 2006 Jul; 6(7):506-20. PubMed ID: 16794634
[TBL] [Abstract][Full Text] [Related]
20. The STAT3 oncogene as a predictive marker of drug resistance.
Barré B; Vigneron A; Perkins N; Roninson IB; Gamelin E; Coqueret O
Trends Mol Med; 2007 Jan; 13(1):4-11. PubMed ID: 17118707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
